ea0073s14.1 | Symposium 14: Complex clinical cases | ECE2021
Mantovani Giovanna
According to the WHO classification and to clinical practice most pituitary tumors are benign, although invasion and aggressive behavior, as well as resistance to somatostatin/dopamine (SS/DA) analogs, occur in 25 – 50% of cases. In particular, genetic forms of acrogigantism (X-linked acrogigantism - X-LAG) are characterized by a very precocious and resistant phenotype associated with microduplications in the Xq26.3 region involving the GPR101 gene. The GPR101 gene encod...